Form 4: Invivyd Executive Julie Green Reports Stock Option and RSU Grants
SEC Form 4 Filing
Julie Green, Chief Human Resources Officer of Invivyd, Inc., reports the acquisition of stock options and restricted stock units (RSUs) in the company.
Summary
- On February 15, 2025, Julie Green, the Chief Human Resources Officer of Invivyd, Inc., was granted stock options to purchase 950,000 shares of common stock at an exercise price of $1.61 per share.
- These options vest over a three-year period, with 1/36th of the shares vesting monthly from one month after the grant date, contingent upon continuous service.
- Green was also granted 300,000 restricted stock units (RSUs), each representing a right to receive one share of common stock.
- These RSUs vest over an eighteen-month period, with one-third vesting every six months from the grant date, also contingent upon continuous service.
- Shares of common stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction in connection with each vesting event.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, indicating stability and alignment of interests. The sentiment is neutral to slightly positive.
Positives
- The grants of stock options and RSUs align Julie Green's interests with those of Invivyd's shareholders, incentivizing her to contribute to the company's long-term success.
Future Outlook
The vesting schedules for both the stock options and RSUs are contingent upon Julie Green's continued service with Invivyd, indicating an expectation of her continued employment.
Industry Context
Granting stock options and RSUs is a common practice in the biotechnology industry to attract, retain, and incentivize key executives. These grants align executive compensation with company performance and shareholder value.
Stakeholder Impact
- Shareholders may view the grants positively as they align executive interests with company performance.
- Employees may see the grants as a sign of the company's commitment to its leadership team.
Key Dates
| Date | Description |
|---|---|
| 02/15/2025 | Date of the transaction (grant of stock options and RSUs) |
| 02/19/2025 | Date of the Form 4 filing |
| 02/14/2035 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.